產(chǎn)品[
CRL-1671 RL95-2 人**內(nèi)膜癌細(xì)胞
]資料
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱:
CRL-1671 RL95-2 人**內(nèi)膜癌細(xì)胞
產(chǎn)品型號(hào):
CRL-1671
產(chǎn)品廠商:
美國(guó)標(biāo)準(zhǔn)生物品收藏中心（ATCC）
產(chǎn)品文檔:
無相關(guān)文檔
簡(jiǎn)單介紹
CRL-1671 RL95-2 人**內(nèi)膜癌細(xì)胞，原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種；細(xì)胞庫(kù)管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！
CRL-1671 RL95-2 人**內(nèi)膜癌細(xì)胞
的詳細(xì)介紹
CRL-1671 RL95-2 人**內(nèi)膜癌細(xì)胞
|
|
CRL-1671?
|
|
$323.00
|
|
|
RL95-2
|
|
|
DL Way
|
|
Biosafety Level:
|
1
|
|
|
frozen
|
|
|
See Propagation
|
|
|
adherent
|
|
|
Homo sapiens (human)
|
|
|
epithelial
|
|
|
Organ: uterus
Tissue: endometrium
Disease: carcinoma
|
|
|
In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
|
|
|
|
|
estrogen receptor, positive
|
|
|
Amelogenin: X
CSF1PO: 10,11
D13S317: 8,12
D16S539: 11,13
D5S818: 10,11
D7S820: 10
THO1: 9,9.3
TPOX: 8
vWA: 16,20
|
|
|
65 years
|
|
|
female
|
|
|
Caucasian
|
|
|
ATCC complete growth medium: A 1:1 mixture of Dulbeccos modified Eagles medium and Hams F12 medium with 10 mM HEPES and 2.0 g/L sodium bicarbonate supplemented with 0.005 mg/ml insulin and 10 fetal bovine serum
Temperature: 37.0°C
|
|
|
Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:5 is recommended
Medium Renewal: Every 2 to 3 days
Remove medium, and rinse with 0.25 trypsin, 0.03 EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
|
|
|
culture medium 95; DMSO, 5
|
|
|
Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2006
recommended serum:ATCC 30-2020
|
|
|
2151: Way DL, et al. Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 19: 147-158, 1983. PubMed: 6339371
22666: Cohen LA. Isolation and characterization of a serially cultivated, neoplastic, epithelial cell line from the N-nitrosomethylurea induced rat mammary adenocarcinoma. In Vitro 18: 565-575, 1982. PubMed: 7118137
29988: Hendricks DT, et al. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res. 57: 2112-2115, 1997. PubMed: 9187105
32565: Yang N, et al. Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter. J. Biol. Chem. 271: 5795-5804, 1996. PubMed: 8621448
|
|
